HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tamara Bavendam Selected Research

Tamsulosin (Flomax)

2/2009Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size.
11/2008Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
11/2008Effects of serum PSA on efficacy of tolterodine extended release with or without tamsulosin in men with LUTS, including OAB.
9/2008Effect of tolterodine extended release with or without tamsulosin on measures of urgency and patient reported outcomes in men with lower urinary tract symptoms.
11/2006Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tamara Bavendam Research Topics

Disease

19Overactive Urinary Bladder (Overactive Bladder)
05/2014 - 07/2005
16Urinary Incontinence
01/2020 - 11/2006
6Lower Urinary Tract Symptoms
01/2020 - 11/2006
4Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2020 - 11/2006
3Nocturia
03/2015 - 07/2005
2Urge Urinary Incontinence (Urge Incontinence)
01/2017 - 11/2008
2Constipation
09/2010 - 12/2007
1Pelvic Floor Disorders
01/2017
1Stress Urinary Incontinence
01/2017
1Pelvic Organ Prolapse
01/2017
1Interstitial Cystitis (Interstitial Cystitis, Chronic)
10/2015
1Urinary Tract Infections (Urinary Tract Infection)
12/2007
1Urinary Retention
11/2006
1Infections
07/2005

Drug/Important Bio-Agent (IBA)

16Tolterodine Tartrate (Detrol)FDA Link
11/2012 - 07/2005
9Muscarinic AntagonistsIBA
01/2017 - 11/2006
7fesoterodineFDA Link
05/2014 - 12/2007
5Tamsulosin (Flomax)FDA LinkGeneric
02/2009 - 11/2006
1Type A Botulinum Toxins (Botox)FDA Link
01/2017
1Cholinergic Antagonists (Anticholinergics)IBA
01/2017
1Polypropylenes (Polypropylene)IBA
01/2017
1SolutionsIBA
03/2015
1Adrenergic Antagonists (Antiadrenergic Agents)IBA
02/2009
1Prostate-Specific Antigen (Semenogelase)IBA
11/2008
1oxybutynin (Tavor)FDA LinkGeneric
07/2005
1tartaric acid (tartrate)FDA Link
07/2005

Therapy/Procedure

3Therapeutics
10/2015 - 02/2009
2Operative Surgical Procedures
01/2020 - 01/2020